Q: What is Myrbetriq used for?

Myrbetriq is used to treat overactive bladder and neurogenic detrusor overactivity .

Q: What are the active ingredients in Myrbetriq?

The active ingredient in Myrbetriq is mirabegron .

Q: What are the side effects of Myrbetriq?

Common side effects of Myrbetriq may include: Increased blood pressure Urinary tract infection Headache and others. Always consult with a healthcare professional about potential side effects.

Q: What drug class is Myrbetriq?

Myrbetriq belongs to the beta-3 adrenergic agonist drug class.

Q: What is the dosage of Myrbetriq and how do I take it?

How to Take Myrbetriq Myrbetriq is available as extended-release tablets and as granules that are mixed into an oral suspension. It is usually taken once a day. It is important to follow the specific instructions provided by a healthcare professional regarding the timing and method of administration. Administration Instructions Extended-release tablets: Swallow the tablet whole with water. Do not crush, chew, or break the tablet, as this can release the medication too quickly and increase the risk of side effects. Oral suspension (granules): This form is typically taken with food. Follow the preparation instructions carefully if mixing the granules at home. General Guidelines Try to take this medication at the same time each day to maintain a consistent level of medicine in your body. If you are taking the tablets, they may be taken with or without food. If you are taking the oral suspension, it should be taken with food. Missed Dose If you miss a dose, take it as soon as you remember. However, if a significant amount of time has passed since the scheduled dose, skip the missed dose and wait until the next scheduled time. Do not take two doses at once to make up for a missed one.

Q: Is Myrbetriq safe during pregnancy and breastfeeding?

Pregnancy There are no adequate or well-controlled studies regarding the use of Myrbetriq in pregnant women. Because human data is limited, the safety of this medication during pregnancy is not fully established. In animal studies, high doses of the drug were associated with developmental issues in the offspring. Consequently, Myrbetriq should be used during pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus. Breastfeeding It is currently unknown whether Myrbetriq passes into human breast milk. However, animal studies have shown that the medication is excreted in the milk of lactating rats. Because many drugs are present in human milk and there is a potential for serious adverse reactions in a nursing infant, healthcare providers typically recommend a careful evaluation. A decision should be made whether to discontinue nursing or discontinue the medication, taking into account the importance of the drug to the mother's health.

Q: What forms and strengths does Myrbetriq come in?

Myrbetriq is supplied in two different oral forms: Extended-release tablets: These tablets are designed to release the medication slowly throughout the day and should be swallowed whole. Extended-release oral suspension: This form is provided as granules that are mixed with water to create a liquid for swallowing. Both forms are designed to provide a steady release of the medication into the body over time.

Q: What is the FDA approval status of Myrbetriq?

FDA Approval Status Myrbetriq (mirabegron) was initially approved by the U.S. Food and Drug Administration (FDA) in 2012. It is available in two formulations: extended-release tablets and granules for oral suspension. Approved Indications The FDA has authorized Myrbetriq for the following specific uses: Overactive Bladder (OAB): To treat adults experiencing symptoms of urge urinary incontinence, urgency, and urinary frequency. It can be used as a standalone treatment or in combination with solifenacin succinate. Neurogenic Detrusor Overactivity (NDO): To treat pediatric patients aged 3 years and older with NDO, a condition where neurological impairment leads to bladder overactivity. Regulatory Warnings and Precautions Myrbetriq does not currently have a boxed warning or a Risk Evaluation and Mitigation Strategy (REMS) program. However, the FDA-approved labeling includes significant warnings regarding the following: Increased Blood Pressure: Myrbetriq can cause a dose-related increase in blood pressure. It is not recommended for use in patients with severe, uncontrolled hypertension. Urinary Retention: There is a risk of urinary retention in patients with bladder outlet obstruction and in those taking muscarinic antagonist medications for overactive bladder. Angioedema: Rare but serious allergic reactions involving swelling of the face, lips, tongue, or throat have been reported.

Question 1

What is Myrbetriq?

Accepted Answer

Myrbetriq is a medication classified as a beta-3 adrenergic agonist. It functions by interacting with specific receptors in the bladder to influence how the bladder muscle behaves during the storage of urine.

By promoting relaxation of the detrusor muscle, the medication assists in the bladder's ability to expand and hold fluid.

Question 2

What is Myrbetriq used for?

Accepted Answer

Myrbetriq is used to treat overactive bladder and neurogenic detrusor overactivity.

Question 3

How does Myrbetriq work?

Accepted Answer

How Myrbetriq Works

Myrbetriq is classified as a beta-3 adrenergic agonist. It works by targeting specific receptors in the bladder muscle to change how the bladder behaves while it is filling with urine.

The bladder is surrounded by a muscle called the detrusor. In a typical cycle, this muscle relaxes to allow the bladder to fill and then contracts when you are ready to urinate. For those with overactive bladder, the detrusor muscle may contract too soon or too often, leading to urgency and frequency.

Myrbetriq helps manage these symptoms in the following ways:

Relaxes the bladder muscle: The medication activates beta-3 receptors on the detrusor muscle, which signals the muscle to stay relaxed while the bladder is storing urine.
Increases bladder capacity: Because the muscle is more relaxed, the bladder can physically hold more urine before you feel the need to use the bathroom.
Reduces sudden urges: By preventing the bladder muscle from contracting prematurely, the medication helps reduce the sudden, uncontrollable urge to urinate and helps decrease the number of daily bathroom trips.

This mechanism is different from other common bladder medications, such as anticholinergics, which work by blocking different nerve signals. By focusing specifically on the relaxation phase of the bladder cycle, Myrbetriq helps the bladder store urine more effectively.

Question 4

What are the active ingredients in Myrbetriq?

Accepted Answer

The active ingredient in Myrbetriq is mirabegron.

Question 5

What are the side effects of Myrbetriq?

Accepted Answer

Common side effects of Myrbetriq may include:

Increased blood pressure
Urinary tract infection
Headache
and others.

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Myrbetriq?

Accepted Answer

Myrbetriq belongs to the beta-3 adrenergic agonist drug class.

Question 7

What is the dosage of Myrbetriq and how do I take it?

Accepted Answer

How to Take Myrbetriq

Myrbetriq is available as extended-release tablets and as granules that are mixed into an oral suspension. It is usually taken once a day. It is important to follow the specific instructions provided by a healthcare professional regarding the timing and method of administration.

Administration Instructions

Extended-release tablets: Swallow the tablet whole with water. Do not crush, chew, or break the tablet, as this can release the medication too quickly and increase the risk of side effects.
Oral suspension (granules): This form is typically taken with food. Follow the preparation instructions carefully if mixing the granules at home.

General Guidelines

Try to take this medication at the same time each day to maintain a consistent level of medicine in your body. If you are taking the tablets, they may be taken with or without food. If you are taking the oral suspension, it should be taken with food.

Missed Dose

If you miss a dose, take it as soon as you remember. However, if a significant amount of time has passed since the scheduled dose, skip the missed dose and wait until the next scheduled time. Do not take two doses at once to make up for a missed one.

Question 8

Is Myrbetriq safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There are no adequate or well-controlled studies regarding the use of Myrbetriq in pregnant women. Because human data is limited, the safety of this medication during pregnancy is not fully established. In animal studies, high doses of the drug were associated with developmental issues in the offspring. Consequently, Myrbetriq should be used during pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus.

Breastfeeding

It is currently unknown whether Myrbetriq passes into human breast milk. However, animal studies have shown that the medication is excreted in the milk of lactating rats. Because many drugs are present in human milk and there is a potential for serious adverse reactions in a nursing infant, healthcare providers typically recommend a careful evaluation. A decision should be made whether to discontinue nursing or discontinue the medication, taking into account the importance of the drug to the mother's health.

Question 9

What forms and strengths does Myrbetriq come in?

Accepted Answer

Myrbetriq is supplied in two different oral forms:

Extended-release tablets: These tablets are designed to release the medication slowly throughout the day and should be swallowed whole.
Extended-release oral suspension: This form is provided as granules that are mixed with water to create a liquid for swallowing.

Both forms are designed to provide a steady release of the medication into the body over time.

Question 10

What is the FDA approval status of Myrbetriq?

Accepted Answer

FDA Approval Status

Myrbetriq (mirabegron) was initially approved by the U.S. Food and Drug Administration (FDA) in 2012. It is available in two formulations: extended-release tablets and granules for oral suspension.

Approved Indications

The FDA has authorized Myrbetriq for the following specific uses:

Overactive Bladder (OAB): To treat adults experiencing symptoms of urge urinary incontinence, urgency, and urinary frequency. It can be used as a standalone treatment or in combination with solifenacin succinate.
Neurogenic Detrusor Overactivity (NDO): To treat pediatric patients aged 3 years and older with NDO, a condition where neurological impairment leads to bladder overactivity.

Regulatory Warnings and Precautions

Myrbetriq does not currently have a boxed warning or a Risk Evaluation and Mitigation Strategy (REMS) program. However, the FDA-approved labeling includes significant warnings regarding the following:

Increased Blood Pressure: Myrbetriq can cause a dose-related increase in blood pressure. It is not recommended for use in patients with severe, uncontrolled hypertension.
Urinary Retention: There is a risk of urinary retention in patients with bladder outlet obstruction and in those taking muscarinic antagonist medications for overactive bladder.
Angioedema: Rare but serious allergic reactions involving swelling of the face, lips, tongue, or throat have been reported.

Question 11

What should I know about Myrbetriq and cost?

Accepted Answer

Factors Influencing Cost

The price you pay for Myrbetriq can be affected by several variables:

Insurance and Medicare: Many insurance plans and Medicare Part D provide coverage for mirabegron. Your out-of-pocket costs will depend on your plan's specific tier for this medication.
Generic vs. Brand Name: A generic version of Myrbetriq is available. Generic medications contain the same active ingredients but usually cost significantly less than brand-name versions.
Pharmacy Selection: Costs can differ between local retail pharmacies and mail-order options.

Ways to Save

There are several resources that may help lower the cost of this medication:

Manufacturer Coupons: The drug manufacturer may offer savings cards or discount programs for patients with commercial insurance.
Patient Assistance Programs: Some organizations provide financial help to patients who meet certain income criteria or lack adequate insurance coverage.

Myrbetriq

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Myrbetriq

Hospitals.net Disclosure